David Smoller
General Partner - Life Sciences Fund @ Cultivation Capital
St Louis, United States
David Smoller is a Series A investor at Cultivation Capital in St Louis focused on Health Care and Biotechnology. Dr. David A. Smoller is a General Partner at Cultivation Capital. He previously worked at Horizon Discovery as a Chief Business Officer and Board Member. David Smoller attended Emory University.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries David Smoller invests in
Stages David Smoller invests in
Countries David Smoller invests in
Investment Focus
Industry
- Health Care 2 (40%)
- Biotechnology 2 (40%)
- Life Science 1 (20%)
- Clinical Trials 1 (20%)
- Health Diagnostics 1 (20%)
Stage
- Series A 2 (40%)
- Series B 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Adarza BioSystems
|
Adarza BioSystems is an early-stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. In addition to performing sophisticated clinical tests within minutes, this technology potentially allowing hundreds of tests to be run simultaneously on a single chip.It was founded in 2008 and headquartered in St Louis, Missouri. | $5M / Series B / Mar 21, 2016 | |
ImmunoPhotonics
|
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a strategic partnership with Veterinary Cancer Therapeutics, LLC. The company was founded in 2008 and is based in Columbia, Missouri. | Series A / Jan 26, 2015 | |
|
Adarza BioSystems
|
Adarza BioSystems is an early-stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. In addition to performing sophisticated clinical tests within minutes, this technology potentially allowing hundreds of tests to be run simultaneously on a single chip.It was founded in 2008 and headquartered in St Louis, Missouri. | $4M / Series A / Oct 02, 2014 | |
|
ImmunoPhotonics
|
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a strategic partnership with Veterinary Cancer Therapeutics, LLC. The company was founded in 2008 and is based in Columbia, Missouri. | Series A / Sep 03, 2014 | |
|
Adarza BioSystems
|
Adarza BioSystems is an early-stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. In addition to performing sophisticated clinical tests within minutes, this technology potentially allowing hundreds of tests to be run simultaneously on a single chip.It was founded in 2008 and headquartered in St Louis, Missouri. | $2M / Series A / Jul 09, 2014 |
Co-Investors
BioGenerator
2 deals together
iSelect Fund
2 deals together
N47
2 deals together
Serra Ventures
2 deals together
Argonautic Ventures
1 deal together
Billiken Angels Network
1 deal together
About Cultivation Capital
Cultivation Capital is a venture capital firm that manages a family of funds focused on early-stage investing. Most of our initial investments are during a startup’s Seed or Series A phase, and our initial checks range from $500k – $3.5M. Our industries of focus include life sciences and health tech, software and IT, agriculture tech, andgeospatial tech.
Cultivation Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alana Mann
Principal
|
|||
Andy Dearing
General Partner
|
|||
Brian Matthews
Co-Founder & General Partner
|
|||
|
David Smoller
General Partner - Life Sciences Fund
|
|||
Dean VandeKamp
General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does David Smoller invest in?
David Smoller invests primarily in Health Care, Biotechnology and Life Science startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did David Smoller last invest?
The most recent investment recorded for David Smoller closed in Mar 2016. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
